Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Borrmann Type IV À§¼±¾Ï°ú À§¸²ÇÁÁ¾ÀÇ ºñ±³: ³ª¼±½Ä CT ¼Ò°ßÀ» Áß½ÉÀ¸·Î Borrmann Type IV Adenocarcinoma versus Gastric Lymphoma: Spiral CT Evaluation

´ëÇѹæ»ç¼±ÀÇÇÐȸÁö 1999³â 41±Ç 6È£ p.1155 ~ 1160
¼Ò¼Ó »ó¼¼Á¤º¸
¼­º¸°æ/Bo Kyoung Seo ±èÀ±È¯/½Å±ÔÈñ/È«¼®ÁÖ/±èÈï¿ø/¹Úö¹Î/Á¤±Ôº´/Á¶Çöµæ/Yun Hwan Kim/Kue Hee Shin/Suk Joo Hong/Hong Weon Kim/Cheol Min Park/Kyoo Byung Chung/Hyun Deuk Cho

Abstract

¸ñÀû: ¹Ì¸¸¼º À§º® ºñÈĸ¦ º¸ÀÌ´Â Barrmann type IV À§¼±¾Ï°ú ÀÌ¿Í À¯»çÇÏ°Ô ¹Ì¸¸¼ºÀ¸·Î
À§º® µÎ²²ÀÇ Áõ°¡¸¦ º¸ÀÌ´Â À§¸²ÇÁÁ¾ÀÇ ³ª¼±½Ä CT ¼Ò°ßÀ» ºñ±³ÇÏ°íÀÚ ÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý: ¹Ì¸¸¼º À§º® ºñÈĸ¦ º¸ÀÌ°í À§ÀýÁ¦¼úÀ» ½ÃÇàÇÑ 30¸íÀÇ Borrmann type IV ¼±
¾Ï°ú 9¸íÀÇ ¸²ÇÁÁ¾ ȯÀÚÀÇ ³ª¼±½Ä CT ¼Ò°ßÀ» ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. CT °Ë»çÀü¿¡
500-700ml ¹°À» ¸ÔÀÎÈÄ 120-140mlÀÇ Á¶¿µÁ¦¸¦ Á¤¸ÆÀ¸·Î ÃÊ´ç 3mlÀÇ ¼Óµµ·Î ÁÖÀÔÇÏ°í,
35-45ÃÊ(Á¶±â)¿Í 180ÃÊ(Áö¿¬±â) ¿µ»óÀ» ¾ò¾ú´Ù. ÀýÆí µÎ²² 10mm, Å×À̺í À̵¿¼Óµµ 10mm·Î
½ºÄµÈÄ 10mm°£°ÝÀ¸·Î Ⱦ´Ü¿µ»óÀ» ¾ò¾ú´Ù. Á¶±â ¿µ»ó¿¡¼­ ºñÈÄµÈ À§º® ÀüÃþÀÇ Á¶¿µÁõ°­ Á¤
µµ¿Í ±ÕÁú¼ºÀ» °üÂûÇÏ°í, À§º® ³»ÃþÀÇ Á¶¿µÁõ°­ ¸ð¾çÀ» »ìÆ캸¾Ò´Ù. Á¶±â¿Í Áö¿¬±â ¿µ»ó¿¡¼­
À§º® µÎ²², À§ ÁÖº¯ºÎÁö¹æ ħÀ± À¯¹« µîÀ» ¾Ë¾Æº¸¾Ò´Ù. ³»ÃþÀÇ Á¶¿µÁõ°­ ¸ð¾çÀº ¿¬¼ÓÀû µÎ²¨
¿î Á¶¿µÁõ°­, ºñ¿¬¼ÓÀû µÎ²¨¿î Á¶¿µÁõ°­, º´º¯ÀÌ ¾ø´Â Á¤»ó À§ ³»Ãþ°ú À¯»çÇÑ ¾ãÀº Á¶¿µÁõ
°­, Á¶¿µÁõ°­ÀÌ µÇÁö ¾Ê´Â °æ¿ì·Î ±¸º°ÇÏ¿´´Ù.
°á°ú: À§º®ÀÇ µÎ²²´Â À§¼±¾Ï¿¡¼­´Â 1.2-3.5cmÀ¸·Î Æò±Õ 2.2cmÀ̾ú°í, À§¸²ÇÁÁ¾Àº 1.2-7.6cm
À¸·Î Æò±Õ 4cmÀ̾ú´Ù. À§ÁÖº¯ºÎ Áö¹æ ħÀ±Àº ¼±¾Ï¿¡¼­´Â 24¸í(80%)¿¡¼­, ¸²ÇÁÁ¾Àº 4¸í
(44%)¿¡¼­ ÀÖ¾ú´Ù. ºñÈÄµÈ À§º® ÀüÃþÀÇ Á¶¿µÁõ°­ Á¤µµ´Â 30¸íÀÇ ¼±¾ÏÁß 15¸í(50%)¿¡¼­ °í
À½¿µÀ¸·Î, 11¸í(44%)¿¡¼­ Áߵ À½¿µÀ¸·Î º¸¿´´Ù. ¸²ÇÁÁ¾ÀÇ °æ¿ì´Â 9¸íÁß 7¸í(78%)¿¡¼­ Àú
À½¿µÀ¸·Î º¸¿´´Ù. À§º® ³»ÃþÀÇ Á¶¿µÁõ°­ ¸ð¾çÀº ¿¬¼ÓÀû µÎ²¨¿î Á¶¿µÁõ°­Àº ¼±¾Ï 18¸í(60%)
¿¡¼­, ºñ¿¬¼ÓÀû µÎ²¨¿î Á¶¿µÁõ°­Àº ¼±¾Ï 9¸í(30%)¿¡¼­ º¸¿´À¸¸ç, ¸²ÇÁÁ¾¿¡¼­´Â µÎ²¨¿î Á¶¿µ
Áõ°­Àº º¸ÀÌÁö ¾Ê¾Ò´Ù. ¾ãÀº Á¶¿µÁõ°­Àº ¼±¾Ï 3¸í(10%), ¸²ÇÁÁ¾ 2¸í(22%)¿¡¼­ º¸¿´°í, ³»Ãþ
Á¶¿µÁõ°­ÀÌ ¾ø¾ú´ø °æ¿ì´Â À§¸²ÇÁÁ¾ 7¸í(78%)À̾ú´Ù.
°á·Ð: ¹Ì¸¸¼º À§º® ºñÈĸ¦ º¸ÀÌ´Â Borrmann type IV À§¼±¾Ï°ú ¸²ÇÁÁ¾À» °¨º°ÇÒ ¶§, 3cmÀÌ
»óÀÇ À§º® ºñÈĸ¦ º¸ÀÌ°í, À§ÁÖº¯ºÎ Áö¹æ ħÀ±ÀÌ Àû°í, Á¶±â ¿µ»ó¿¡¼­ ºñÈÄµÈ À§º®ÀÌ ÀúÀ½¿µ
À¸·Î Á¶¿µÁõ°­µÇ¸ç, ƯÈ÷ À§º® ³»ÃþÀÇ Á¶¿µÁõ°­ÀÌ ¾ø°Å³ª Á¤»ó ºÎÀ§¿Í À¯»çÇÏ°Ô ¾ã°Ô Á¶¿µ
Áõ°­µÉ ¶§ À§¸²ÇÁÁ¾À» ´õ ½Ã»çÇÏ´Â ¼Ò°ßÀ̶ó°í »ý°¢ÇÑ´Ù.
#ÃÊ·Ï#
Purpose: To distinguish the spiral CT findings of Borrmann type IV adenocarcinoma
from those of gastric lymphoma with diffuse gastric wall thickening
Materials and Methods: We retrospectively reviewed the spiral CT scans of 30 patients
with Borrmann type IV adenocarcinoma and nine with gastric lymphoma with diffuse
gastric wall thickening. In all patients the respective condition was pathologically
confirmed by gastrectomy. CT scanning was performed after peroral administration of
500-700ml of water. A total of 120-140ml bolus of nonionic contrast material was
administered intravenously at a flow rate of 3ml/sec and two-phase images were
obtained at 35-45 sec(early phase) and 180sec(delayed phase) after the start of bolus
injection. Spiral CT was performed with 10mm collimation. 10mm/sec table feed and
10mm reconstruction. We evaluated the degree and homogeneity of enhancement of
thickened entire gastric wall, and the enhancement pattern of gastric inner layer, as seen
on early-phase CT scans. On early and delayed views, the thickness of gastric wall and
the presence of perigastric fat infiltration were determined. The enhancement patterns of
gastric inner layer were classified as either continuous or discontinuous thick
enhancement, thin enhancement, of nonenhancement.
Results: The thickness of gastric wall was 1.2-3.5cm(mean 2.2cm)in cases of
adenocarcinoma and 1.2-7.6cm(mean 4cm) in lymphoma. Perigastric fat infiltration was
seen in 24 patients with adenocarcinoma(80%) and four with lymphoma(44%). In those
with adenocarcinoma, the degree of enhancement of entire gastric wall was hyperdense
in fifteen patients(50%) and isointense in eleven (37%). Seven patients with
lymphoma(78%) showed hypodensity. In those with adenocarcinoma, continuous thick
enhancement of gastric inner layer was seen in 18 patients(60%) and discontinuous thick
enhancement in nine(30%). In lymphoma cases, no thick enhancement was observed.
Thin enhancement of gastric inner layer was demonstrated in three patients with
adenocarcinoma(10%) and two with lymphoma(22%). In seven patients with
lymphoma(78%), there was no enhancement.
Conclusion: The following early-phase finding are highly suggestive of gastric
lymphoma: a gastric wall thickness of more than 3cm; no or minimal perigastric fat
infiltration, hypodense enhancement of thickened entire gastric wall; and no or thin
enhancement of gastric inner layer.

Å°¿öµå

Stomach CT; Stomach neoplasms; Lymphoma CT;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS